Normal view MARC view ISBD view

Let the Body'n'Brain Games Begin: Toward Innovative Training Approaches in eSports Athletes. [electronic resource]

By:

Martin-Niedecken, Anna Lisa

Contributor(s):

Schättin, Alexandra

Publication details: Frontiers in psychology 2020Description: 138 p. digitalISSN:

1664-1078

Online resources:

Available from publisher's website

In: Frontiers in psychology vol. 11

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

to post a comment.

Back to results

41 Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes.
by Gallichotte, Emily N
42 Unsuspected Dengue as a Cause of Acute Febrile Illness in Children and Adults in Western Nicaragua.
by Reller, Megan E
43 Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity.
by Weiskopf, Daniela
44 Oligomeric state of the ZIKV E protein defines protective immune responses.
by Metz, Stefan W
45 The mechanism of differential neutralization of dengue serotype 3 strains by monoclonal antibody 8A1.
by Zhou, Yang
46 Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever.
by Messer, William B
47 Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone.
by Gallichotte, Emily N
48 Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses.
by Metz, Stefan W
49 Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies.
by Gallichotte, Emily N
50 Dissecting Antibodies Induced by a Chimeric Yellow Fever-Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals.
by Henein, Sandra
51 Seroepidemiology of Dengue, Zika, and Yellow Fever Viruses among Children in the Democratic Republic of the Congo.
by Willcox, Alexandra C
52 Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype.
by Metz, Stefan W
53 Burden of dengue infection and disease in a pediatric cohort in urban Sri Lanka.
by Tissera, Hasitha
54 Innovative and New Approaches to Laboratory Diagnosis of Zika and Dengue: A Meeting Report.
by Goncalves, Adriana
55 Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses.
by Grifoni, Alba
56 Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines.
by Swanstrom, Jesica A
57 Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera.
by de Alwis, Ruklanthi
58 Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies.
by Raut, Rajendra
59 Physiological temperatures reduce dimerization of dengue and Zika virus recombinant envelope proteins.
by Kudlacek, Stephan T
60 Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika.
by Andrade, Paulina